Results 251 to 260 of about 6,202,090 (405)
Dysregulation of STS in keratinocytes promotes calcium signaling and differentiation. [PDF]
Kwon TU+4 more
europepmc +1 more source
Optical recording of light-evoked calcium signals in the functionally intact retina
Winfried Denk, Peter B. Detwiler
openalex +1 more source
Pancreatic ductal adenocarcinoma (PDAC) is a disease with very poor prognosis due to therapeutic limitations. We investigated the antitumor effects of cystatin A (CSTA) in PDAC murine models. We are first to confirm that CSTA enhances T helper type 1‐mediated antitumor effects through promotion of dendritic cells and M1 macrophage activity. CSTA can be
Alessandro Nasti+8 more
wiley +1 more source
Dysregulated calcium signaling in the aged macaque entorhinal cortex associated with tau hyperphosphorylation. [PDF]
Bathla S+7 more
europepmc +1 more source
Calcium compartments in vascular smooth muscle cells as detected by aequorin signal [PDF]
Fujio Abe+3 more
openalex +1 more source
Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer
mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor
Khrystany T. Isebia+17 more
wiley +1 more source
Endoplasmic Reticulum Calcium Signaling in Hippocampal Neurons. [PDF]
Shkryl VM.
europepmc +1 more source
Cross-talk between calcium and cAMP-dependent intracellular signaling pathways. Implications for synergistic secretion in T84 colonic epithelial cells and rat pancreatic acinar cells. [PDF]
M. Vajanaphanich+5 more
openalex +1 more source
FOXL2 c.402C>G mutation drives granulosa cell tumors. Using CRISPR technology, we selectively corrected this mutation, reducing malignancy and increasing sensitivity to dasatinib and ketoconazole. Transcriptomic changes revealed potential therapeutic targets, demonstrating CRISPR's promise for treating this rare ovarian cancer.
Sandra Amarilla‐Quintana+17 more
wiley +1 more source